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Materials and Methods: 
Cell culture, stable cell line construction and imaging sample preparation 
Human U2OS cells containing a LacO array (#1, #2 or #3) in the genome were grown in low-
glucose DMEM (ThermoFisher, 10567014) with 10% fetal bovine serum (HyClone FBS 
SH30910.03) and 1% penicillin-streptomycin (ThermoFisher, 15140122). Cell line #1 containing 
~50,000 LacO elements in the array was described in Janicki et al. (25). Cell line #2 containing 
~15,000 LacO elements in the array was created by co-transfecting 3 plasmids: the first encoding 
puromycin selection cassette, the second containing 256 LacO repeats and the third containing 
the luciferase-CFP-24×MS2 fusion reporter gene under the control of 7 TetO elements and a 
CMV promoter. Cell line #3 contains ~40,000 LacO elements in the array that were inserted in 
tandem in quasi-absence of any other regulation element (e.g. promoter). This line was described 
in (46). The number of integrated LacO repeats was quantified by qPCR using 2 different pairs 
of oligonucleotides priming (either before or after the tandem LacO) once per integrated LacO 
repeats-containing plasmid (Table S4). We also used the plasmid pBslacO for an absolute 
quantification of the number of plasmids integrated per genome (for our calculation we estimated 
the amount of DNA per cell to be 6 pg). The calculation details are included in Table S5. 
Human A673 Ewing’s sarcoma cells (ATCC® CRL-1598) and 293T cells (ATCC® CRL-
3216) were grown in high-glucose DMEM (ThermoFisher, 10566016) with 10% FBS and 1% 
penicillin-streptomycin. For live-cell imaging, the medium was identical except that phenol-red-
free DMEM (ThermoFisher, 31053028) was used. U2OS, A673 and 293T cells were cultured at 
37°C with 5% CO2. 
The A673 cell line stably expressing H2B-Halo was generated using PiggyBac transposition 
and drug selection. This cell line was used in the SPT experiments to correct for dye 
photobleaching and axial cell or chromatin drift. Briefly, the cDNA encoding H2B-Halo was 
cloned into a PiggyBac vector co-expressing a G418 resistance gene, and this vector was co-
transfected together with a SuperPiggyBac transposase vector into the A673 cell line using 
Fugene 6 (Promega, E2691) according to the manufacturer’s instructions. 48 hours after 
transfection, we started with selection by adding 0.5 mg/ml G418. Untransfected A673 cells 
were treated with G418 in parallel, and selection was judged to be complete once no 
untransfected cells remained (~ 1 week). The cells were further selected for 2 weeks under 0.25 
mg/ml G418 before stocks were frozen.  
The construction of U2OS cell line stably expressing H2B-Halo was described in (24). The 
LacO-array-containing U2OS cell line #2 stably expressing Halo-RPB1 was generated using an 
α-amanitin resistant expression vector encoding an N-terminally Halo-tagged α-amanitin 
resistant (N792D) RPB1. Briefly, cells were transfected using Fugene 6 following 
manufacturer’s instruction, a-amanitin (Sigma, A2263) was used during the stable selection 
process at a concentration of 2 µg/ml and was used thereafter in permanence in the culture of the 
cells at a concentration of 1 µg/ml to avoid endogenous RPB1 re-expression as described in (47). 
The EWS/FLI1 knockout A673 cell lines stably expressing exogenous EWS/FLI1 or 
EWS(YS)/FLI1 were generated using PiggyBac transposition and drug selection following the 
same protocol used for generating the A673 line stably expressing H2B-Halo. The PiggyBac 
vector co-expresses a puromycin resistance gene. The transfected cells were selected with 
puromycin (1 µg/µl) for over 2 weeks before stocks were frozen.  
For live-cell single-molecule imaging, the cells were plated on 25 mm circular No. 1 cover 
glasses (Azer Scientific, 200251) that were plasma-cleaned prior to use. To image transiently 
expressed proteins, we transfected the cells with the target construct using Fugene 6, then grew 
them for 24 hours. To image stably expressed proteins, we grew the cells on the cover glasses 
overnight for sample preparation. The cells were then labeled with relevant HaloTag or SNAPf-
tag dyes at the indicated concentration for 15 min (Halo) or 30 min (SNAPf) and washed twice 
(for each wash: remove medium, rinse twice with PBS, incubate in fresh medium for 30 min). At 
the end of the final wash, the medium was changed to phenol-red-free imaging medium as 
described above.   
The same protocol was followed to prepare fixed cell samples for confocal fluorescence 
imaging, except that the cells were grown on 18 mm circular No. 1 cover glasses (VWR 
VistaVision, 16004-300). For FRAP experiment and live-cell imaging during hexanediol 
treatment, sample preparation was identical except that cells were grown on glass-bottom (No. 
1.5, 14 mm diameter) 35 mm dishes (MatTek, P35G-1.5-14-C) and not labeled with dyes when 
EYFP or mCherry fluorescence was monitored.  
CRISPR/Cas9-mediated genome editing 
We created knock-in and knockout cell lines roughly according to published procedures (36), 
except exploiting the HaloTag in fluorescence-activated cell sorting (FACS) for EWS/FLI1-Halo 
knock-in cells.  
To create EWS/FLI1 knockout cells, we transfected A673 cells with a Cas9 plasmid. The 
Cas9 plasmid was slightly modified from that distributed from the Zhang lab (36): 3xFLAG-
SV40NLS-pSpCas9 was expressed from a CBh promoter; the sgRNA was expressed from a U6 
promoter; and mVenus was expressed from a PGK promoter. To create EWS/FLI1-Halo knock-
in cells, we co-transfected A673 using a repair plasmid together with the Cas9 plasmid (3:1 mass 
ratio for repair plasmid to Cas9 plasmid). For the repair vector, we modified a pUC57 plasmid to 
incorporate coding sequences for TEV protease recognition epitope (EDLYFQS), HaloTag and 
FLAG-tag flanked by ~750 bp of genomic homology sequence (homology arm) of FLI1 C-
terminus on either side. The TEV linker sequence was between FLI1 and HaloTag. Since the 
wild-type A673 does not express the wild-type FLI1 (33), only the endogenous EWS/FLI1 was 
tagged and expressed in the knock-in A673. We introduced synonymous mutations (last 11 
codons of FLI1 before TAG) in the homology sequence, where necessary, to prevent the Cas9-
sgRNA complex from cutting the repair vector.  
In each case, we designed two or three sgRNAs using the Zhang lab CRISPR design tool 
(http://tools.genome-engineering.org), cloned them into the Cas9 plasmid and transfected A673 
using individual Cas9-sgRNA plasmid only (for knockout) or together with the repair vector (for 
knock-in). 24 hours after transfection, we then pooled cells transfected with each of the sgRNAs 
individually and FACS-sorted for YFP (mVenus) positive, successfully transfected cells. To 
generate the HaloTag knock-in, we grew the YFP-positive cells for 19 days, labeled them with 
500 nM HaloTag TMR ligand (Promega, G8251), FACS-sorted for HaloTag-positive cells and 
plated one cell per well into 96-well plates. To generate EWS/FLI1 knockout, we similarly grew 
up the YFP-positive cells and plated single cells in 96-well plates via FACS.  
Clones were then expanded and screened by genomic PCR (for knock-in, using a genomic 
primer external to the homology sequence and an internal HaloTag primer) or western blot (for 
knockout). Successfully edited clones were further verified with western blot (for knock-in only) 
and Sanger sequencing. All the knockout clones we acquired contain double knockouts of 
EWS/FLI1 and wild-type EWSR1, which shares the same N-terminus with EWS/FLI1 but does 
not maintain oncogenic transformation in A673 (48). For further studies, we chose a knock-in 
clone that expresses tagged EWS/FLI1 at a level similar to the endogenous untagged EWS/FLI1 
in wild-type A673, and a knockout clone that has relatively high transfection efficiency in 
preparation of samples for live-cell single-molecule imaging (Fig. 5D-F). Sequences for primers 
and sgRNAs are provided in Table S3. All plasmids used in this study, including the ones for 
genome-editing and transient transfections, are available upon request. 
Antibodies  
The following antibodies were used for western blots: anti-FLI1 (Abcam, ab133485), anti-
EWSR1 (Abcam, ab133288) and anti-β-Actin (Sigma, A2228). The following antibodies were 
used for immunofluorescence: anti-EWSR1 (Abcam, ab54708) and donkey anti-Mouse 
secondary antibody, Alexa Fluor 647 (ThermoFisher Scientific, A-31571). 
Luciferase assay 
The firefly luciferase reporter contains a 500-bp promoter region (-1.6 kb to -1.1 kb) from the 
endogenous human NR0B1 gene upstream of a minimal SV40 promoter (33) (precious gift from 
Stephen Lessnick). The 500-bp promoter region contains a 23x GGAA microsatellite. We co-
transfected 293T cells with the firefly reporter, pRL-TK Renilla reporter plasmid and the 
relevant transcription factor (TF) cDNA plasmid (or an empty vector with an identical backbone 
as a control), and then measured the firefly and Renilla luciferase activity with the Dual-
Luciferase® Reporter Assay System (Promega, E1960) following the manufacturer’s 
instructions. The firefly luciferase activity was normalized to the Renilla luciferase activity to 
control for transfection efficiency. The relative firefly luciferase activity reflects transactivation 
capacity of the tested TF at the GGAA-microsatellite-driven promoter. Five (for Fig. 5G) or 
three (for Fig. S6C) independent replicates were performed for each condition. We did not detect 
the firefly luciferase activity using EWS/FLI1 cDNA and a control reporter vector (pGL3-
Promoter) where luciferase expression is driven by the sole SV40 promoter (Fig. 5G, S6C), 
which confirms the essential role of GGAA-TF interaction in transactivation.  
RT-qPCR and analyses 
Total RNA was purified from cells using Trizol (ThermoFisher Scientific, 15596026) and 
quantified by Nanodrop. 500 ng of total RNA was retrotranscribed to cDNA using Maxima First 
Strand cDNA Synthesis Kit for RT-qPCR, with dsDNase (ThermoFisher Scientific, K1671). 5 µl 
of 1:20 cDNA dilutions were used for quantitative PCR with SYBR Select Master Mix for CFX 
(Applied Biosystems, ThermoFisher) on a BIO-RAD CFX Real-time PCR system. Five 
independent replicates were performed for each gene. To normalize the data, we used the 
average value of 5 invariant transcripts (GAPDH, MED12, NAE1, TUBULIN, BGALT3) and 
calculated the normalized fold change for each target gene. Primers used are listed in Table S4.  
Soft agar colony formation assay 
To examine the malignant transformation capacity of endogenous EWS/FLI1-Halo, we seeded 
wild-type, EWS/FLI1 knockout, or EWS/FLI1-Halo knock-in A673 cells at a density of 5 x 104 
per well in a 6-well plate in 0.4% SeaPlaque GTG agarose (Fisher, BMA50111) and IMDM 
(ThermoFisher, 12200036) medium containing 20% FBS and 1% penicillin-streptomycin, 
cultured the cells in agar at 37°C with 5% CO2 for 15 days, and then stained the cells by 
applying to each well 200 µl of 1 mg/ml nitro blue tetrazolium chloride (NBT, ThermoFisher, 
N6495) in PBS. After culturing the stained cells in agar for 24 hours, we took images of the 
wells with a ChemiDoc MP imaging system (Bio-Rad). The live colonies appear as distinct dots 
on agar (Fig. S6D). We counted the number of sizable colonies (diameter > 70 µm) for 
quantitative analyses. To examine the transformation function of EWS(YS)/FLI1, the protocol 
was identical except that wild-type A673, EWS/FLI1 knockout A673 or EWS/FLI1 knockout 
A673 expressing exogenous EWS(YS)/FLI1 were seeded at a density of 1.5 x 104 per well in a 
12-well plate (Fig. S10B), and stained with NBT 10 days after seeding. Three independent 
replicates were performed for each condition in Fig. S6D and S10B. 
Fluorescence correlation spectroscopy (FCS) and analyses 
Cells transfected with a fluorescent protein construct were plated on high-tolerance 150 µm glass 
coverslips (Marienfeld) and imaged at a single point with a Zeiss LSM880-NLO AxioExaminer 
microscope equipped with a 40x/1.2 W Korr M27 objective. Autocorrelation functions (ACFs) 
were computed with the Zen software. The autocorrelation function at a delay time of zero is 
equal to the inverse mean number of diffusing fluorescent particles in the observation volume 
under the condition that fluctuations in the intensity are due only to diffusing fluorophores (18, 
19). ACFs were first manually examined for two criteria: (1) absence of additional sources of 
fluctuations at small time delays (e.g. shot noise and triplet-singlet reactions), and (2) a constant 
mean fluorescent intensity in time, indicating an absence of photobleaching. ACFs out of 
compliance with these criteria were discarded. Estimates of the mean number of molecules in the 
observation volume were compared with a standard curve of purified fluorescent proteins to 
determine the concentration of fluorophores in the nucleoplasm. To measure the concentration of 
endogenous EWS/FLI1-Halo in A673 cells, we labeled the cells with 200 nM Halo ligand JF549 
and used a standard curve of free JF549 in cell culture medium. 
 
    Due to the high density of fluorophores and internal heterogeneity of fluorescent proteins at 
the LacO array, ACFs cannot reliably be acquired within the array. Instead, to estimate the 
number of fluorophores at the LacO array, we first acquired an ACF in the nucleoplasm (outside 
any puncta) of LacO-containing U2OS cells transfected with the fluorescent protein of interest, 
then a z-stack of images through the cell (0.5 µm per step, 31 steps). The intensity within LacO 
arrays was then integrated and compared with the integrated intensity at an identically sized 
volume in the nucleoplasm to estimate the number of fluorophores inside the LacO array. 
Fluorescence recovery after photobleaching (FRAP) and analyses 
FRAP was performed on an inverted laser scanning confocal microscope (Zeiss, LSM 710 
AxioObserver) equipped with 34-channel spectral detection, a motorized stage, a full incubation 
chamber maintaining 37°C and 5% CO2, a heated stage, an X-Cite 120 illumination source as 
well as several laser lines (405, 458, 488, 514, 561, 591, 633 nm). The 561 nm laser and the epi-
illumination mode were used for FRAP measurements. Images were acquired with a 40x Plan 
NeoFluar NA1.3 oil-immersion objective under control of the Zeiss Zen software.  
To measure the FRAP dynamics of mCherry-labeled LCD-LacI or LacI at the LacO array 
(Fig. 1E, S3), we acquired 500 frames at one frame per 1.5 seconds with the first 3 frames 
acquired before the bleach pulse for the measurement of baseline fluorescence of the bleach spot 
and the whole nucleus. We chose to photobleach a circular spot (radius ranging from 0.6 to 2 
µm) that just covered the LacO-associated hub using the 561 nm laser at maximum intensity. To 
measure the FRAP dynamics of JF549-labeled endogenous or transiently expressed EWS/FLI1-
Halo (Fig. S8C), we acquired 1000 frames at one frame per 0.3 second with the first 5 frames 
acquired before the bleach pulse. A circular bleach spot (radius ~0.7 µm) was chosen in a region 
with homogenous fluorescence and at least 1 µm from nuclear or nucleolar boundaries.  
To correct for xy-drift of the bleached spot due to live cell movement during movie 
acquisition, we used a published ImageJ plugin “Template Matching and Slice Alignment” 
(https://sites.google.com/site/qingzongtseng/template-matching-ij-plugin#description). Then we 
used three steps of normalization to quantify the FRAP signal in the bleach spot. First, we 
normalized the mean intensity of the bleach spot and the whole nucleus at time t to the respective 
pre-bleaching baseline intensity, i.e., Ifrap(t)/Ifrap-pre and Iwhole(t)/Iwhole-pre. Secondly, we normalized 
the relative bleach spot intensity to the relative nuclear intensity by 
Ifrap-2norm(t) = (Ifrap(t)/Ifrap-pre)/(Iwhole(t)/Iwhole-pre).  (1) 
Then we calculated the bleach depth (ΔIfrap), i.e., the difference between the double-normalized 
FRAP intensity before and at the first frame (t1) after bleach pulse by  
ΔIfrap = 1-Ifrap-2norm(t1).    (2)  
Finally, we normalized the bleach depth to 100%, and the triple-normalized FRAP intensity 
became 
 Ifrap-3norm(t) = 1-(1- Ifrap-2norm(t))/ΔIfrap .  (3) 
For each experiment, we averaged the drift-corrected and normalized FRAP curves from 
multiple single cells to generate a mean FRAP curve. In order to choose an appropriate model to 
fit the FRAP dynamics of LacO-associated hubs, we ensured that the FRAP dynamics of 
mCherry-TAF15 LCD-LacI or mCherry-LacI at the LacO array were independent of the bleach 
spot size (Fig. S3A-B), suggesting that the observed FRAP dynamics are independent of 
diffusion (20, 26). We found the FRAP dynamics are best fitted with the reaction-dominant two-
binding-state model below  
Ifrap-3norm(t) = 1-Ae-k1t--Be-k2t ,   (4) 
where k1 and k2 are fast and slow dissociation rate constants, respectively. A single exponential 
equation does not fit the FRAP traces well as the one-binding-state model does not properly 
describe the FRAP dynamics here that involve two binding states (data not shown). After model 
fitting, we used the slow dissociation rate constant for further analyses on how LCD changes the 
dynamics of LacI-LacO specific interaction, as the fast dissociation process in the FRAP 
dynamics likely reflects nonspecific LacI-chromatin interactions.  
Live-cell imaging of LCD hubs during hexanediol treatments 
On the previously described confocal microscope with the incubation chamber maintaining 37°C 
and 5% CO2, live LacO-array-containing U2OS cells expressing EYFP-labeled Sp1 LCD-LacI or 
FUS LCD-LacI were imaged under epi-illumination using the 514 nm laser with a frame 
acquisition time of 1.938 sec except where otherwise noted.  
We prepared fresh stock solutions of 1,6-hexanediol (Aldrich, 240117) or 2,5-hexanediol 
(Aldrich, H11904) with different m/v concentrations (20%, 10% or 4%) in the phenol-red-free 
medium for live-cell imaging. Before starting with image acquisition, we had 1 ml of phenol-red-
free medium in the 35 mm dish. Without pausing imaging of LCD hubs, we added 1 ml of the 
pre-warmed hexanediol stock solution to the dish to reach a final concentration of 10%, 5% or 
2%. The time of hexanediol addition was the time “0” in Fig. 2C-D and S5C-D. The number of 
intra-nuclear puncta was quantified using the “Find Maxima” function of ImageJ (49).  
3D DNA Fluorescence in situ hybridization (FISH) 
We followed the published 3D DNA FISH protocol (22, 50) except that the EWS/FLI1-Halo 
knock-in A673 cells were labeled with the JF549 HaloTag ligand before fixation. The DNA 
FISH probes were prepared by incorporating Red 650 dUTP (enhanced Cy5, Enzo, ENZ-42522) 
into relevant bacterial artificial chromosome (BAC) DNA with the Nick Translation DNA 
Labeling System (Enzo, ENZ-42910) according to the manufacturer’s instructions. The 
following BAC clones (purchased from BACPAC Resources Center at Children’s Hospital 
Oakland Research Institute) were used for generating locus-specific FISH probes: RP11-426N1 
(for CAV1), RP11-622M2 (for FCGRT), RP11-467M9 (for ABHD6), RP11-711N9 (for KDSR), 
RP11-66P3 (for KIAA1797), RP11-431J16 (for non-GGAA #1, detecting ADGRA3), RP11-
248F15 (for non-GGAA #2, detecting REEP5). Ultrapure, genomic DNA-free BACs were 
extracted with QIAGEN Large-Construct Kit (QIAGEN, 12462) before used as the template 
DNA in nick translation reactions.  
Confocal fluorescence imaging and analyses 
Z stacks of fixed cell samples were acquired on the previously described confocal microscope 
with a pinhole size of 1 airy unit and a slice interval of 0.4 µm. We used 488 nm, 514 nm and 
561 nm lasers to excite fluorescence of JF500-labeled Halo-RPB1 (JF500 λmax=500 nm, λem=524 
nm, ε500=60,760 M-1 cm-1), EYFP-LCD-LacI and mCherry-LCD respectively, which were 
expressed solely or in combination in LacO-containing U2OS cells. We used 561 nm and 633 
nm lasers to excite fluorescence of JF549-labeled EWS/FLI1-Halo and Red 650 dUTP-labeled 
DNA FISH in knock-in A673 respectively. Before acquiring all the fluorescence images, we 
carefully set the laser intensity and microscope detectors to make sure that no pixel in the images 
was saturated.	For simultaneous 2-color imaging (Fig. 1F, 2A, 4D, 5C, S4, S5B, S9B), we used 
proper emission filters and ensured no bleed-through between the two channels by imaging fixed 
cell samples that contain either fluorophore under the same 2-color imaging settings.  
To measure the nuclear fluorescence intensity of EYFP- or mCherry-labeled LCD-LacI or 
LacI alone in individual cells (Fig. 1C-D, S2), we included all the pixels of the cell nucleus, that 
is, the LacO-affiliated hub, puncta unaffiliated with the LacO array, and the low-intensity regions 
outside the hubs were all taken into account in the measurement. Then we calculated the mean 
nuclear TF concentration by comparing the fluorescence intensity with the standard curves (Fig. 
S1B-C). 
Figure S5A illustrates the way we quantified enrichment of mCherry-LCD at LacO arrays 
bound by EYFP-LCD-LacI (Fig. 2B, S9A, C-D). First, we selected the slice (#N) in the EYFP-
channel z stack where the LacO-associated hub was brightest, manually located the LacO array 
center in the cell nucleus and plotted the radial profiles surrounding this center pixel in both the 
EYFP image and slice #N in the mCherry-channel z stack. The EYFP intensity radial profile 
allows us to locate the concentration peak and periphery of the LacO-associated hub. Next, from 
the mCherry intensity radial profile, we extracted the intensity at the peak location (Ipeak) and 
averaged two intensity values immediately outside the periphery location with an interval 
ranging from 0.23 to 0.45 µm (Iperiphery). Finally, we calculated the peak to periphery intensity 
ratio (Ipeak/Iperiphery) as a measure of mCherry-LCD enrichment at the LacO array. A ratio above 1 
suggests LCD-LCD interactions. 
To quantify enrichment of JF500-labeled Halo-RPB1 at the LacO array bound by mCherry-
FET LCD-LacI or mCherry-LacI, we first selected the slices in the mCherry-channel z stack that 
covered ~80% of the intensity of a LacO-associated hub, averaged these slices as well as the 
corresponding JF500 slices, and located the LacO array center pixel in the average mCherry 
image. Then we cropped a square region (8.30 µm x 8.30 µm) in the average mCherry and JF500 
images centering the LacO array center pixel. We processed tens of LacO arrays following the 
above procedure, averaged the cropped square images in both channels (Fig. 1G, left), and 
plotted the average radial profile of JF500 intensity surrounding the center pixel (Fig. S4B). To 
acquire the baseline radial profile of JF500 intensity in the nucleus outside the LacO array, we 
manually selected 10 non-LacO pixels from each cell nucleus in the average mCherry image, 
each pixel being away from nuclear or nucleolar boundaries with distances comparable to the 
distances between the LacO array center and the boundaries. Then we plotted the radial profiles 
of JF500 intensity surrounding these pixels in all the cell nuclei under analyses and calculated 
the average radial profile. Subtracting this baseline radial profile from the radial profile at LacO 
array resulted in the background-free radial profile of Halo-RPB1 (Fig. S4C). We compared the 
mean Halo-RPB1 (Pol II) intensity values at the center of the LacO array (first points on the 
background-free radial profiles in Fig. S4C) bound by mCherry-labeled FET LCD-LacI or LacI 
alone in Fig. 1G (bar plot on the right). To calculate the error bar for each condition in Fig. 1G, 
we used the bootstrap method (45) to generate 2000 resampled image sets from the original set 
of JF500 (Halo-RPB1) images centering the LacO array, calculated the mean Halo-RPB1 
intensity at LacO array center of each image set and then the standard deviation of the mean 
values. We also took the bootstrapped mean value as the test statistic and performed two-sample 
t-test to calculate p-values.  
The procedure we used to evaluate enrichment of JF549-labeled EWS/FLI1-Halo at specific 
genes visualized by DNA FISH (Fig. 4D-E) was similar except that the cropped square regions 
were slightly larger (8.51 µm x 8.51 µm), images of more loci (~1000) were processed for each 
gene and fewer non-FISH-puncta pixels (2 to 4 per cell nucleus) were manually selected for 
measurement of baseline JF549 intensity. From the DNA FISH and JF549 images, we cropped 
square regions centering all the FISH puncta (Fig. 4D) or non-FISH-puncta pixels, averaged 
them respectively, and got a two-color FISH puncta image or baseline image (averaged from 
non-FISH-puncta square regions). Subtracting the baseline image from the FISH puncta image 
resulted in the averaged background-free two-color image of FISH puncta and EWS/FLI1-Halo 
(Fig. 4E).  
Lattice light sheet microscopy 
The image volumes of EWS/FLI1 hubs were generated by the lattice light sheet (LLS) 
microscope (21). Each image volume includes 100 image frames, which were acquired at 10 ms 
exposure time with minimal photobleaching. The collected data have spatial resolution of 230 
nm in XY and 370 nm in Z. 
In preparation of experiments, LLS scope was aligned and the imaging chamber with heating 
block was preheated to 37°C. A673 cells were seeded on 5 mm coverslips (Warner Instruments) 
and placed into the imaging chamber. The samples were then imaged on the LLS scope using 
Bessel beams arranged in a square lattice configuration in dithered mode (21). Live cells 
immersed into imaging medium were imaged by exciting each plane with a 560 nm laser at ~10 
µW (at the rear aperture of the excitation objective) for 10 ms. The fluorescence generated 
within the specimen was collected by a detection objective (CFI Apo LWD 25XW, 1.1 NA, 
Nikon), filtered through a 440/521/607/700 nm BrightLine quad-band bandpass filter (Semrock), 
and eventually recorded by an ORCA-Flash 4.0 sCMOS camera (Hamamatsu). The cells were 
imaged by sample scanning mode and the dithered light sheet at 300 nm step size, thereby 
capturing a volume of ~25 µm x 51 µm x 30 µm (corresponding to 500 × 512 × 100 pixels in 
deskewed data). The generated raw images were deskewed and then deconvoluted by running 8 
Richardson-Lucy iterations. 
Single-particle tracking (SPT) and analyses 
Single-molecule imaging for Halo-tagged EWS/FLI1 variants (wild-type, EWS(YS)/FLI1, FLI1 
DBD) was conducted on a custom-built Nikon (Nikon Instruments Inc.) TI microscope described 
in detail in (24). Single-molecule imaging of various Halo-tagged LCDs was conducted on 
another Nikon microscope with the same equipment except a LUNV laser unit with alignment-
free monolithic optical based beam combiner and AOTF modulation, providing guaranteed 
output powers at the following 4 wavelengths with 2 single mode optical fiber outputs: 405 nm 
(20 mW), 488 nm (70 mW), 561 nm (70 mW), and 647 nm (125 mW). Motorized ND filters 
were installed on all laser lines. We took images with a 100x/NA 1.49 oil-immersion TIRF 
objective (Nikon apochromat CFI Apo TIRF 100x Oil) under highly inclined and laminated 
optical sheet (HILO) illumination (51) using following laser lines: 488 nm for EYFP; 561 nm for 
JF549; 405 nm and 633 nm or 647 nm for photo-activation and illumination of PA-JF646, 
respectively. The incubation chamber maintained a humidified 37°C atmosphere with 5% CO2 
and the objective was similarly heated to 37°C for live-cell experiments.  
To measure the residence times (RTs) of endogenous EWS/FLI1-Halo in and outside its hubs, 
we labeled knock-in A673 cells with 200 nM JF549 and 20 nM PA-JF646. High-concentration 
JF549 labeling allows visualization of EWS/FLI1 hubs, whereas low-concentration PA-JF646 
labeling allows real-time tracking of individual EWS/FLI1 molecules. We kept the intensity of 
the 405 nm laser low enough that it only photo-activated a handful of PA-JF646-labeled 
EWS/FLI1-Halo molecules at a time in the nucleus. Using a long image acquisition time (500 
ms), we blurred out fast moving molecules into the background and visualized individual stable 
EWS/FLI1 binding events (23)(Movie S3). To minimize photobleaching of dyes, we took time-
lapse images (500 ms image acquisition time) in the JF549 channel with a 10 sec interval, and 
continuously acquire images in the PA-JF646 channel with constant low-intensity excitation at 
633 nm.    
All the single-molecule images taken in the PA-JF646 channel were processed using a 
custom-written MATLAB implementation of the MTT algorithm (52). A GUI of this 
implementation, SLIMfast (53), is available in the supplemental materials of (54). Briefly, single 
molecules are localized using 2-dimensional Gaussian fitting (approximating the microscope 
PSF) subject to a generalized log-likelihood ratio test with a ‘localization error’ threshold (in the 
range of 10-6-10-7), with the option of allowing deflation to detect molecules partially obscured 
by others. Tracking, that is connecting localizations between consecutive frames, was limited by 
setting a maximal expected diffusion constant, and takes the trajectory history into account as 
well as allowing for gaps due to blinking or missed localizations. We used the following 
algorithm parameters for SPT: localization error: 10-7; deflation loops: 3; blinking (frames): 2; 
maximum number of competitors: 1; maximal expected diffusion constant (µm2/s): 0.1. 
Thousands of single-molecule trajectories were recorded in each cell.  
We processed the JF549 images using a custom-written Macro program in ImageJ, which 
defined the EWS/FLI1-Halo hubs as intra-nuclear regions above a fluorescence intensity 
threshold, assigned pixel values of in- and outside-hub regions as 1 and 0 respectively, and 
therefore generated a dynamic mask of hubs. Of note, both false positives and false negatives 
inevitably existed in mask generation as 1) the HILO illumination was not perfectly 
homogeneous across the cell nucleus; 2) JF549 slowly photobleached during movie acquisition; 
3) hubs were small, crowded, surrounded by significant fluorescence background, and slowly 
moved in and out of the focus; and 4) one intensity threshold was used for hub definition 
throughout the movie. Using a custom-written Matlab program, we separated all the single-
molecule trajectories from a cell into in- and outside-hub groups based on the fraction of lifetime 
(F) a molecule located in the “hub region”. We found the average in-hub lifetime fraction (Fave) 
of all the trajectories in a cell was in the range of 20~30%. Thus we used the following trajectory 
sorting standard in calculating EWS/FLI1-Halo RTs presented in this study: F > 50% for in-hubs 
and F < 5% for outside-hubs. We also tried alternative sorting standard: F > (2Fave-10%) for in-
hubs and F < 10% for outside-hubs, which resulted in slightly different absolute in- and outside-
hub RTs of EWS/FLI1-Halo but did not affect our conclusions. We did not use stringent 
standards like F = 1 or F > 0 for in-hub molecule definition due to errors in hub detection 
throughout the movie acquisition.  
After sorting, we recorded the lengths of trajectories in either group and used them to generate 
a survival probability (1-CDF) (Fig. S8B). Then we fitted the survival probability curve to a two-
term exponential model below and extracted RTs of EWS/FLI1-Halo corresponding to specific 
and nonspecific binding (Fig. S8A) (23, 24, 55) 
 P(t) = Ae-k1t-+(1-A)e-k2t ,   (5) 
1/k1 = τns ,  1/k2 = τs , 
where τs and τns are specific and nonspecific RTs, respectively. We only focused on the specific 
RT.  
To correct for dye photobleaching and axial cell or chromatin drift (24), we measured the 
specific RT (τH2B) of histone H2B (largely immobile on chromatin) by performing SPT of PA-
JF646-labeled H2B-Halo that was stably expressed in A673 cells under identical illumination 
intensity and image acquisition settings (Fig. S8B). Then we corrected the specific RT of 
EWS/FLI1-Halo by following equation and used the corrected RT for further analyses.  
τcorrected = 1/(1/ τs-1/τH2B),   (6) 
We recorded 20 min movies from at least 6 EWS/FLI1-Halo knock-in and 4 H2B-Halo A673 
cells per day, conducted at least 3 independent experiments on different days and presented the 
average corrected RT.  
We performed FRAP of JF549-labeled EWS/FLI1-Halo in the knock-in A673 cells (Fig. 
S8C), fitted the FRAP curve with the two-binding-state model described above, and extracted the 
long-lived RT (1/k2) of EWS/FLI1-Halo corresponding to slow dissociation to be 78 sec. The 
fact that the long-lived RT of EWS/FLI1-Halo measured by FRAP is close to the in-hub RT (90 
sec) and overall RT (59 sec) measured by SPT cross-validates the two methods in measurement 
of specific RTs.    
We followed the same procedure of 2-color single-molecule imaging acquisition and data 
analyses to measure the in-hub and outside-hub RTs of Halo-tagged EWS/FLI1 or its mutants 
(EWS(YS)/FLI1 or FLI1 DBD) that were transiently expressed in EWS/FLI1 knockout A673. 
To measure the RTs of Halo-tagged EWS or EWS(YS) LCD at EWS/FLI1-SNAPf hubs in the 
knockout A673 cells, we used the same procedure except that 1) a SNAPf-tag ligand cp-JF549 
(200 nM) was used to label EWS/FLI1-SNAPf instead for visualizing EWS/FLI1 hubs; 2) the 
JF549 channel acquired images continuously; and 3) SPT of PA-JF646-labeled Halo-LCDs was 
performed with low-intensity excitation at 647 nm instead of 633 nm.  
To measure the RTs of various Halo-LCDs in U2OS cells at EYFP-labeled LCD hubs that 
were either LacO-array-associated or non-array-affiliated, the procedure was identical except 
that 1) the cells were only labeled with one HaloTag ligand, PA-JF646 (2 nM) for single-
molecule imaging; 2) images of LCD hubs were continuously acquired in the EYFP channel with 
488 nm laser excitation; 3) SPT of PA-JF646-Halo-LCDs was performed with 647 nm 
excitation; 4) U2OS cells stably expressing H2B-Halo were used for photobleaching correction; 
and 5) an in-hub Halo-LCD molecule was defined as that localized in a hub for more than once 
throughout its trajectory (F > 0). The reason for a different in-hub molecule definition here was 
that these LCD hubs were significantly brighter (relative to background intra-nuclear 
fluorescence), larger, fewer and more sparsely distributed (Fig. 3A) than the EWS/FLI1 hubs in 
A673 (Fig. 4C), which led to much lower errors in hub detection.  
Supplementary Text:  
All the codes for imaging data analyses have been submitted to GitHub and are publicly 
available at https://github.com/Shasha-Chong/CodeFor2018SciencePaper.   
 
Fig. S1. Two methods to measure protein concentration in live cells.  
(A) Bright field and confocal fluorescence images of live U2OS cells containing a LacO array 
(#3, with ~40,000 LacO repeats and a single transcription unit) and transiently expressing 
mCherry-LacI. Purified mCherry was added to the imaging media, reaching the final 
concentration indicated above the images. The fluorescence intensities of free mCherry outside 
live cells were measured in three images to generate the standard concentration curve of 
mCherry.    
(B-C) Fluorescence intensity as a function of free mCherry (B) or EYFP (C) concentration 
measured by the imaging method shown in (A). Error bars represent standard errors. 
(D) FCS measurements of purified mCherry at known concentrations in the media used for live-
cell imaging. The y-intercept of the ACF, G(0) (not considering shot noise), is used to estimate 
the inverse mean number of molecules (N) in the observation volume and generate the standard 
concentration curve for mCherry. 
(E-F) Copy number in the observation volume as a function of free mCherry (E) or EYFP (F) 
concentration measured by FCS as shown in (D). Error bars represent standard deviations. 
  
 
Fig. S2. LCD can form interaction hubs at the targeted LacO array or spontaneously as 
non-LacO-affiliated intranuclear puncta upon overexpression.   
(A) Mean concentration of EYFP-labeled TAF15 LCD-LacI (red) or LacI (blue) at the LacO 
array (#1, ~50,000 LacO repeats) as a function of mean nuclear concentration of the TF. Each 
dot represents one cell. 
(B) Radius of the LacO array (#1) bound by EYFP-labeled TAF15 LCD-LacI (red) or LacI 
(blue) as a function of mean nuclear concentration of the TF.  
(C) Copy number of EYFP-labeled Sp1 LCD-LacI (red) or LacI (blue) molecules bound to LacO 
arrays (#1) as a function of mean nuclear concentration of the TF. Concentrations and copy 
numbers in (A), (B) and (C) were measured by fluorescence intensity comparison. 
(D-E) Copy number of EYFP-labeled (D) or mCherry-labeled (E) TAF15 LCD-LacI (red) or 
LacI (blue) molecules bound to LacO array #1 (D) or #2 (~15,000 LacO repeats) (E) as a 
function of mean nuclear concentration of the TF. Concentrations and copy numbers were 
measured by FCS. Each dot represents one cell.  
(F) Copy number of mCherry-labeled TAF15 LCD-LacI (red) or LacI (blue) molecules bound to 
LacO array (#3, with ~ 40,000 LacO repeats and a single transcription unit) as a function of 
mean nuclear concentration of the TF. (A) to (F) suggest that a LacO array can accumulate more 
copies of LCD-LacI than of LacI alone, thus the array can mediate formation of LCD hubs that 
involve extensive LCD self-interactions.  
(G-H) Number of intranuclear puncta of EYFP-labeled TAF15 LCD-LacI (G) or Sp1 LCD-LacI 
(H) (red) compared with LacI (blue) as a function of mean nuclear concentration of the TF. 
TAF15 LCD-LacI and Sp1 LCD-LacI, but not LacI alone, can self-aggregate at high expression 
levels. Concentrations and copy numbers in (F), (G) and (H) were measured by TF concentration 
measured by fluorescence intensity comparison. 
  
 
Fig. S3. The formation of an LCD interaction hub slows down the dissociation of LCD-LacI 
from the LacO array according to FRAP.  
(A) FRAP curves at the LacO array (#1, ~50,000 LacO repeats) bound by mCherry-TAF15 
LCD-LacI in one U2OS cell with different photobleaching spot radii (R). The FRAP dynamics 
are independent of the radius.  
(B) Half life (τ1/2) of FRAP at the LacO array (#1) bound by mCherry-LacI (blue) or mCherry-
TAF15 LCD-LacI (red) as a function of the photobleaching spot radius in one U2OS cell. τ1/2 is 
independent of the radius. (A) and (B) both suggest that FRAP dynamics at the LacO array is 
reaction-dominant.   
(C-E) Averaged FRAP curve at LacO arrays (#1) bound by mCherry-labeled LacI (C, blue), 
TAF15 LCD-LacI (D, red) or FUS LCD-LacI (E, green) fitted with a reaction-dominant two-
binding-state model (fitted curves in black, model shown by the inner equation in C). The slow 
dissociation rate constants reflect specific LacI-LacO interaction dynamics. Error bars represent 
standard deviations. Top panels show the residuals from the fitted model.   
(F) Slow (k2) dissociation rate constants of mCherry-labeled LacI (blue), TAF15 LCD-LacI 
(red) or FUS-LacI (green) at the LacO array (#1) extracted from the two-binding-state model. 
Fusing an LCD to LacI significantly reduces the dissociation rate. Error bars represent 95% 
confidence bounds for the fitted dissociation rate constants.  
  
 
Fig. S4. LacO-array-associated LCD hubs recruit RNA Pol II. 
(A) Confocal fluorescence images show that Halo-RPB1 (labeled with HaloTag ligand JF500 at 
200 nM, green) is enriched at LacO array #2 (~15,000 LacO repeats) bound by mCherry-labeled 
FUS LCD-LacI or TAF15 LCD-LacI, but not LacI (red). 
(B) Averaged Halo-RPB1 image at LacO arrays (#2) bound by mCherry-EWS LCD-LacI 
(N=69). The radial profile of Halo-RPB1 is plotted centering the LacO array as marked on the 
images. 
(C) Average background-free radial profile of Halo-RPB1 (Pol II) at the LacO array #2 bound by 
mCherry-labeled TAF15 LCD-LacI (blue), FUS LCD-LacI (green), EWS LCD-LacI (magenta), 
or LacI (black). FET LCD-LacI enriches Pol II at the LacO array while LacI does not.  
(D) Averaged image of Halo-RPB1 (labeled with HaloTag ligand JF500 at 200 nM, green) at 
mCherry-TAF15 LCD-LacI (red) puncta unaffiliated with LacO arrays (N=574 from 5 cells). 
  
 
Fig. S5. Assays for studying selective protein-protein interactions involved in LCD hub 
formation.  
(A) Representative images to illustrate quantification of mCherry-LCD at the LacO array bound 
by EYFP-LCD-LacI. We first located the center of LacO array in the cell nucleus according to 
the EYFP channel image (upper left) and plotted radial profiles surrounding the center pixel in 
both EYFP and mCherry channel images (lower). The EYFP intensity radial profile allows us to 
locate the concentration peak and periphery of LacO-associated LCD hubs (lower left). Next, 
from the mCherry intensity radial profile (lower right), we extracted the intensity at the peak 
location (Ipeak) and immediately outside the periphery location (Iperiphery, averaged from two 
adjacent points in the radial profile, each representing the average intensity in a 0.25-µm-thick 
circular ring area), and calculated the peak to periphery intensity ratio (Ipeak/Iperiphery) as the 
measure of mCherry-LCD enrichment at the LacO array. A ratio above 1 suggests LCD-LCD 
interactions. 
(B) Averaged EWSR1 immunofluorescence images shows the endogenous EWSR1 (red) is 
enriched at LacO array #1 (~50,000 LacO repeats) bound by EYFP-labeled EWS LCD-LacI but 
not LacI (green). The anti-EWSR1 antibody does not target EWS LCD. Possibly due to difficulty 
in antibody penetration into the dense LacO array region in the absence of specific interactions, 
we even detected depletion of anti-EWSR1 antibody at the LacO arrays bound by LacI only 
(lower middle). This result confirms that LacO-associated LCD hubs interact with not only 
overexpressed but also endogenous LCDs.  
(C) Number of nuclear puncta formed by FUS (solid lines) or Sp1 (dashed lines) LCD surviving 
over time upon addition of 1,6-HD or 2,5-HD at different concentrations. 2,5-HD melts self-
aggregated LCD hubs more slowly and less thoroughly than 1,6-HD at the same concentration. 
Error bars represent standard errors. 
(D) Due to disruption of LacO-array-associated LCD hubs, the apparent radius of the array 
bound by EYFP-LCD-LacI decreases upon addition of HDs. The effect of 1,6-HD is more 
significant than 2,5-HD. Error bars represent standard errors. 
  
 
Fig. S6. Genome editing of A673 cells 
(A-B) Schematics for genome editing of A673 cells to generate EWS/FLI1-Halo knock-in and 
EWS/FLI1 knockout lines. We used a single-guide RNA (sgRNA, underlined red sequence) 
targeting the genomic sequence near the FLI1 stop codon (blue TAG) for the knock-in (A), and 
an sgRNA targeting the EWS start codon (underlined blue ATG) for the knockout (B). PAM 
sequences are in green. RNA-guided Cas9 generates a double-strand break at the targeted 
genomic loci. In the presence of a donor plasmid that contains the HaloTag and Flag-tag coding 
sequences followed by a stop codon and flanked by two homology arms (HA-L and HA-R), The 
break can be repaired by the homology directed repair (HDR) pathway to incorporate the 
HaloTag to the C-terminus of FLI1 (33)(A). On the other hand, in the absence of a donor 
plasmid, the break is repaired through non-homologous end joining (NHEJ) (36), which can 
create indels (a T insertion in this case) near the start codon of EWS that inhibits expression of 
EWS/FLI1 (B).    
(C) Luciferase assay using a reporter construct that contains a GGAA microsatellite upstream of 
a minimal SV40 promoter. EWS/FLI1-Halo activates the reporter as efficiently as the wild-type 
EWS/FLI1. **: statistically significant difference of pairwise comparisons (p < 0.01, two-sample 
t-test). Error bars represent standard errors (n = 3).  
(D) Soft agar colony formation assay to examine the cancerous transformation capacity of 
modified A673 cell lines. EWS/FLI1-Halo knockin (KI) A673 cells are able to form colonies in 
agar similar to wild-type (WT) A673, albeit with lower efficiency. In contrast, as expected the 
EWS/FLI1 knockout (KO) A673 cells do not grow in agar.  
(E) Number of sizable colonies (diameter > 70 µm) formed by WT, EWS/FLI1 KO and 
EWS/FLI1-Halo KI A673 cells in soft agar, quantified from (D). **: p < 0.01, two-sample t-test. 
Error bars represent standard errors (n = 3).  
  
 
Fig. S7. Intranuclear distribution of EWS/FLI1 
(A) Fluorescence intensity as a function of free HaloTag ligand JF549 concentration measured 
by the imaging method shown in Fig. S1A. Error bars represent standard errors. By comparing 
the nuclear fluorescence intensity of endogenous EWS/FLI1-Halo in A673 cells (labeled with 
200 nM JF549) with this standard concentration curve, we estimated the nuclear concentration of 
the TF to be 181 ± 31 nM. The error bar represents standard deviation. The nuclear concentration 
is also confirmed by FCS measurement. 
(B) Distribution of the endogenous EWS/FLI1 copy number per hub at GGAA microsatellites. 
The median number of EWS/FLI1 molecules directly binding to a GGAA microsatellite via 
DNA-protein interactions is 8 (red dashed line). The mean concentration of 120 hubs randomly 
chosen from five A673 cells were measured by fluorescence intensity comparison. (inner 
equation) The protein copy number in each hub Nin-hub was estimated using the in-hub 
concentration Cin-hub and the hub volume Vhub. We estimated Vhub by assuming the hub is a 
sphere with a radius measured from single cell images. The median copy number of EWS/FLI1 
per hub is 24, significantly larger than what is recruited to a GGAA microsatellite via DNA-
protein interactions. 
(C) Confocal fluorescence images of EWS/FLI1-Halo or FLI1 DBD-Halo transiently expressed 
in U2OS cells. The cells were labeled with HaloTag ligand JF549 (200 nM). At comparable 
expression levels, EWS/FLI1 forms more distinct hubs in the cell nucleus than FLI1 DBD. 
(D) Total copy number of EWS/FLI1-Halo (red) or FLI1 DBD-Halo (blue) in all the intranuclear 
hubs as a function of mean nuclear concentration of the TF. Concentrations and copy numbers 
were measured by fluorescence intensity comparison. Each dot represents one cell. The 
EWS/FLI1-Halo hubs were defined using the “Find Maxima” function of the ImageJ program 
(49) with a noise tolerance level determined by eye-balling that allows all the intranuclear hubs 
to be selected as local maxima. The FLI1-Halo hubs in each cell nucleus were defined by the 
“Find Maxima” function with the noise tolerance used for analyzing cells expressing comparable 
levels of EWS/FLI1-Halo. EWS/FLI1 hubs enrich more molecules than FLI1 DBD hubs, 
suggesting that the EWS/FLI1 hubs involve LCD-LCD interactions.  
  
 
Fig. S8. Live-cell DNA-binding dynamics of EWS/FLI1  
(A) A plot of the uncorrected survival probability of individual EWS/FLI1-Halo (PA-JF646 
labeled) molecules determined by live-cell SPT (red bars), which is fitted to a two-term 
exponential model (black line, inner equation) that extracts EWS/FLI1 residence times (RTs) for 
specific (ts) and nonspecific (tns) DNA binding. 
(B) Uncorrected survival probability as a function of time for EWS/FLI1 in or outside its hubs. 
The survival probability of the chromatin bound H2B is plotted as a comparison. The 
measurement of H2B RT is used to correct EWS/FLI1 RTs for drift and dye photobleaching.  
(C) The FRAP dynamics of endogenous EWS/FLI1-Halo in knock-in A673 are comparable to 
transiently expressed EWS/FLI1-Halo in knockout A673. The cells were labeled with HaloTag 
ligand JF549 (200 nM). 
  
 
Fig. S9. Y-to-S but not Y-to-F mutations in the EWS LCD abolish LCD-LCD interactions  
(A) Quantification of the enrichment of mCherry-labeled LCD (font color: red) at the LacO array 
bound by EYFP labeled LCD-LacI fusion proteins (font color: green), where the LCD is either 
wild-type EWS or EWS with m = 3, 7, 10, 17 or 29 Y-to-S mutations (YSm). mCherry 
enrichment above 1 suggests LCD-LCD interactions at the LacO array. LCD-LCD interactions 
progressively decrease with increasing number of Y-to-S mutations starting from m = 10. **: p < 
0.01, two-sample t-test. NS: non-statistically significant difference. Error bars represent standard 
errors. 
(B) EWS(YS29) LCD is not enriched at the LacO array bound by EWS LCD-LacI, and 
conversely, EWS LCD is not enriched at the array bound by EWS(YS29) LCD-LacI, suggesting 
that EWS and EWS(YS29) LCDs do not interact with each other. On the contrary, EWS and 
EWS(YF29) LCDs interact with each other. 
(C-D) Quantification of the enrichment of mCherry-labeled LCD (font color: red) at the LacO 
array bound by EYFP labeled LCD-LacI fusion proteins (font color: green), where the LCD is 
either EWS, EWS(YS29) (C) or EWS(YF29) (D). mCherry enrichment above 1 suggests LCD-
LCD interactions at the LacO array. **: statistically significant difference above 1 (p < 0.01, 




Fig. S10. Assays for studying effects of Y-to-S mutations in the EWS LCD on EWS/FLI1 
functions 
(A) RT-qPCR measures the mRNA levels of 5 different invariant genes in WT A673, EWS/FLI1 
KO A673 and the EWS/FLI1 KO lines that stably express exogeneous (Exo) EWS/FLI1 or 
EWS(YS)/FLI1. For each invariant gene, the mRNA level is graphed as a fold change relative to 
the amount of RNA present in the WT A673 line (set to 1). Error bars represent standard 
deviations (n = 5). For each EWS/FLI1-target gene (Fig. 5H), its normalized level of expression 
is calculated by normalizing its mRNA level with the mRNA level averaged from the 5 invariant 
genes shown here. 
(B) Soft agar colony formation assay to examine the cancerous transformation capacity of 
EWS(YS)/FLI1. EWS/FLI1 KO A673 cells stably expressing exogenous EWS/FLI1, but not 
EWS(YS)/FLI1, are able to form colonies in agar. As controls, WT but not EWS/FLI1 KO A673 
cells grow in agar. This result shows that Y-to-S mutations abolish the cancerous transformation 
capacity of EWS/FLI1. 
Table S1. Amino acid composition of FET and Sp1 LCDs studied with the LacO array 
assay 
Protein EWS FUS TAF15 Sp1 
LCD residues 47-266 2-214 2-205 2-507 
Percentage of 
individual 
amino acid (%) 
Ala (A) 8.6 1.9 1.0 7.3 
Arg (R) 0.5 0.5 4.3 1.2 
Asn (N) 1.8 3.3 4.8 7.5 
Asp (D) 1.8 2.3 8.2 1.3 
Cys (C) 0.0 0.0 0.0 0.2 
Gln (Q) 16.7 20.0 17.3 14.6 
Glu (E) 0.9 0.5 3.8 3.7 
Gly (G) 9.0 24.7 18.3 11.5 
His (H) 0.0 0.0 2.4 0.2 
Ile (I) 0.0 0.0 0.0 5.0 
Leu (L) 0.5 0.0 0.0 7.1 
Lys (K) 0.5 0.0 1.0 1.0 
Met (M) 0.5 0.5 1.0 1.3 
Phe (F) 0.0 0.0 0.0 1.3 
Pro (P) 13.1 5.1 2.4 5.0 
Ser (S) 16.2 23.7 18.8 14.4 
Thr (T) 14.9 5.1 3.4 10.8 
Trp (W) 0.0 0.0 0.0 0.4 
Tyr (Y) 13.1 12.6 13.0 0.8 
Val (V) 2.3 0.0 0.5 5.4 
Pyl (O) 0.0 0.0 0.0 0.0 
Sec (U) 0.0 0.0 0.0 0.0 
 
Table S2. P-values determined by one-tailed Student’s t-test 
Related 
figure Alternative hypothesis P-value 
Fig. 1G 
Average Halo-RPB1 enrichment by EWS LCD-LacI at 
the LacO array is greater than by LacI 
0 (too small to be 
reported by Matlab) 
Average Halo-RPB1 enrichment by FUS LCD-LacI at the 
LacO array is greater than by LacI 
0 (too small to be 
reported by Matlab) 
Average Halo-RPB1 enrichment by TAF15 LCD-LacI at 
the LacO array is greater than by LacI 
0 (too small to be 
reported by Matlab) 
Fig. 2B 
mCherry-TAF15 enrichment at the LacO array bound by 
EYFP-TAF15-LacI is greater than 1 9.3024e-14 
mCherry-FUS enrichment at the LacO array bound by 
EYFP-FUS-LacI is greater than 1 7.6749e-07 
mCherry-EWS enrichment at the LacO array bound by 
EYFP-EWS-LacI is greater than 1 2.2562e-07 
mCherry-Sp1 enrichment at the LacO array bound by 
EYFP-Sp1-LacI is greater than 1 3.7129e-04 
mCherry-EWS enrichment at the LacO array bound by 
EYFP-TAF15-LacI is greater than 1 5.8369e-04 
mCherry-FUS enrichment at the LacO array bound by 
EYFP-TAF15-LacI is greater than 1 0.0449 
mCherry-TAF15 enrichment at the LacO array bound by 
EYFP-FUS-LacI is greater than 1 0.0026 
mCherry-FUS enrichment at the LacO array bound by 
EYFP-EWS-LacI is greater than 1 0.0452 
mCherry-TAF15 enrichment at the LacO array bound by 
EYFP-EWS-LacI is greater than 1 0.0165 
Fig. 3B 
Residence time of EWS LCD in LacO-associated EWS-
LacI hubs is greater than in self-aggregated EWS LCD 
hubs 
0.0081 
Residence time of FUS LCD in LacO-associated FUS-
LacI hubs is greater than in self-aggregated FUS LCD 
hubs 
0.0129 
Fig. 5B Residence time in hubs is longer than outside hubs 1.8059e-08 
Fig. 5D 
Residence time of EWS/FLI1 in hubs is longer than 
EWS(YS)/FLI1 0.0159 
Residence time of EWS/FLI1 in hubs is longer than FLI1-
DBD 6.9710e-04 
Fig. 5F Residence time of EWS LCD in EWS/FLI1 hubs is longer than EWS(YS) LCD 0.0320 
Fig. 5G 
GGAA-containing reporter is activated by EWS/FLI1 
more efficiently than EWS(YS)/FLI1  4.3159e-06 
GGAA-containing reporter is activated by EWS/FLI1 
more efficiently than FLI1-DBD 2.5010e-05 
Fig. 5H FCGRT expression in the WT A673 is higher than EWS/FLI1 KO A673 9.8124e-05 
FCGRT expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 0.0032 
CYP4F22 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 1.7125e-07 
CYP4F22 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 1.8769e-07 
CCK expression in the WT A673 is higher than 
EWS/FLI1 KO A673 5.6432e-09 
CCK expression in the Exo EWS/FLI1 condition is higher 
than Exo EWS(YS)/FLI1 condition 1.7689e-06 
FEZF1 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 2.5088e-07 
FEZF1 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 5.5223e-05 
NKK2-2 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 0.0288 
NKK2-2 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 0.0304 
CACNB2 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 4.7444e-07 
CACNB2 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 1.0687e-04 
GSTM4 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 8.9997e-09 
GSTM4 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 8.5400e-05 
PPP1R1A expression in the WT A673 is higher than 
EWS/FLI1 KO A673 8.2648e-10 
PPP1R1A expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 7.3388e-05 
NR0B1 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 4.3640e-04 
NR0B1 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 6.0396e-06 
KDSR expression in the WT A673 is higher than 
EWS/FLI1 KO A673 5.3393e-04 
KDSR expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 7.3582e-04 
ABHD6 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 3.3504e-09 
ABHD6 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 0.0025 
BAF155 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 2.9416e-04 
EZH2 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 0.0367 
EZH2 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 0.0047 
PRKCB expression in the WT A673 is higher than 
EWS/FLI1 KO A673 1.1705e-04 
PRKCB expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 2.7318e-06 
UGT3A2 expression in the WT A673 is higher than 
EWS/FLI1 KO A673 1.3304e-07 
UGT3A2 expression in the Exo EWS/FLI1 condition is 
higher than Exo EWS(YS)/FLI1 condition 5.6997e-06 
Fig. S6C 
GGAA-containing reporter is activated by EWS/FLI1 
more efficiently than empty vector 8.1950e-04 
GGAA-containing reporter is activated by EWS/FLI1-
Halo more efficiently than empty vector 0.0020 
Fig. S6E 
WT A673 cells form greater number of colonies than 
EWS/FLI1 KO A673 1.7164e-07 
EWS/FLI1-Halo KI A673 cells form greater number of 
colonies than EWS/FLI1 KO A673 6.2759e-09 
Fig. S9A 
mCherry-EWS(YS7) enrichment at the LacO array bound 
by EYFP-EWS(YS7)-LacI is greater than mCherry-
EWS(YS10) enrichment at the LacO array bound by 
EYFP-EWS(YS10)-LacI 
0.0032 
mCherry-EWS(YS10) enrichment at the LacO array bound 
by EYFP-EWS(YS10)-LacI is greater than mCherry-
EWS(YS17) enrichment at the LacO array bound by 
EYFP-EWS(YS17)-LacI 
0.0078 
mCherry-EWS(YS17) enrichment at the LacO array bound 
by EYFP-EWS(YS17)-LacI is greater than mCherry-
EWS(YS29) enrichment at the LacO array bound by 
EYFP-EWS(YS29)-LacI 
1.9347e-07 
Fig. S9C mCherry-EWS enrichment at the LacO array bound by EYFP-EWS-LacI is greater than 1 2.2562e-07 
Fig. S9D 
mCherry-EWS(YF29) enrichment at the LacO array bound 
by EYFP-EWS(YF29)-LacI is greater than 1 
9.0988e-14 
mCherry-EWS(YF29) enrichment at the LacO array bound 
by EYFP-EWS-LacI is greater than 1 1.5186e-14 
mCherry-EWS enrichment at the LacO array bound by 
EYFP-EWS(YF29)-LacI is greater than 1 
4.2377e-20 
 
Table S3. Sequences for primers and sgRNAs used in genome editing of A673 cells 
Name/description Sequence (5’-3’) Experiment 
FLI1 C-terminal sgRNA1 ACGTGCCTTCACACTTAGGC 
EWS/FLI1-Halo Knock-in FLI1 C-terminal sgRNA2 CGTGCCTTCACACTTAGGCA 
FLI1 C-terminal sgRNA3 ACCCACGTGCCTTCACACTT 
FLI1 genome F1 TTCAGGCCTTTCTAGATGAAGAGATTCAAA Genotyping 
Internal Halo primer R1 TCGCCCAGGACTTCCACATAATGG 
EWS N-terminal sgRNA1 CGGGTGAGTATGGTGGAACT EWS/FLI1 Knockout EWS N-terminal sgRNA2 GGAGAGAAAATGGCGTCCAC 
 
Table S4. Sequences for primers used in RT-qPCR 
Name/description Sequence (5’-3’) Experiment 
Primers targeting FCGRT TGGCGATGAGCACCACTACT 
Quantification of 


























Primers targeting NR0B1 AGGGGACCGTGCTCTTTAAC CTGAGTTCCCCACTGGAGTC 
Primers targeting FEZF1 TTCAGCCGAGGCTCTCCTAATG GCCTGAAACCTTTTCCGCACAC 
Primers targeting NKX2-2 CAGCGACAACCCGTACAC GACTTGGAGCTTGAGTCCTGA 




Primers targeting EZH2 TGGGAAAGTACACGGGGATA TATTGACCAAGGGCATTCAC 
Primers targeting GAPDH GGTCTCCTCTGACTTCAACA GTGAGGGTCTCTCTCTTCCT 




Primers targeting ABHD6 CTTGGTCTGCGTGGACAT GCTTCAGGCATTCTACAAA 
Primers targeting KDSR GGATGGCTCCAGTAACTTC ACGAACTATGCTGTCAAAAC 
Primers targeting CACNB2 CACCCTAGCCTCTAATTCAC TCTTGACTGGTTCCACACTA 
Primers targeting GSTM4 CCAGAATACTTGGAGGAACT TCATAGGCGAGGAAATCTAC 
Primers targeting TUBULIN TTTTGGCCAGATCTTTAGAC ACATCCAGGACAGAATCAAC 
Primers targeting MED12 CTTTGGTCCGGCAACTTC TATGTTGGTACTGGGCTGTG 
Primers targeting NAE1 GATCGCTGCATAAATATCAC 
AAATTTCCTTGACCCTCTTT 
Primers targeting BGALT3 CCGTTGCTATGAACAAGTTT GCCATTCATCTTCAGGTACT 
Primers targeting beginning of 
LacO repeats-containing plasmid 
ACGGCCAGTGAATTGTAA Estimating the 
number of LacO 
repeats in each 
LacO array  
GGGGGATCCACTAGTTCT 










Target of primer 
pair 
Target copy 
number in 10 
ng of gDNA by 
qPCR 
Copy number 
of target per 






Number of LacO 
repeats per genome 
normalized by 
globin gene number 
#2 
Before LacO 
repeats on the 
array-containing 
plasmid  
101235 60.74 256 13331 
#2 
After LacO 
repeats on the 
array-containing 
plasmid  
129306 77.58 256 17027 
#2 Globin gene 3888 2.33 / / 
#3 
Before LacO 
repeats on the 
array-containing 
plasmid  
1979170 1187.50 40 35474 
#3 
After LacO 
repeats on the 
array-containing 
plasmid  
2572921 1543.75 40 46116 
#3 Globin gene 4463 2.68 / / 
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